The Forsyth Institute, located in Cambridge, Massachusetts, is one of the leading centers for dental and craniofacial research in the world. It was envisioned in 1908 by James Forsyth, who left $500,000 in his will for the establishment of a dental infirmary for poor children in Boston.

During the past decade, The Forsyth Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Forsyth Institute" #1 sponsor was "The Forsyth Institute" with 4 trials, followed by "Colgate Palmolive" with 2 trials sponsored, "Noveome Biotherapeutics, formerly Stemnion" with 2 trials sponsored, "Amyndas Pharmaceuticals S.A." with 1 trials sponsored and "Cargill" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Forsyth Institute" #1 collaborator was "National Institute of Dental and Craniofacial Research (NIDCR)" with 3 trials as a collaborator, "The Forsyth Institute" with 2 trials as a collaborator, "ActivMed Practices & Research" with 1 trials as a collaborator, "Boston University" with 1 trials as a collaborator and "Delta Dental Plan Massachusetts" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "The Forsyth Institute" are "Gingivitis" (4 trials), "Periodontal Diseases" (3 trials), "Periodontitis" (3 trials), "Dental Caries" (2 trials) and "Periodontal Disease" (2 trials). Many other conditions were trialed in "The Forsyth Institute" in a lesser frequency.

Most popular intervention types in "The Forsyth Institute" are "Drug" (9 trials), "Other" (6 trials), "Device" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.24% Sodium Fluoride Dentifrice" (1 trials), "0.3X ACCS" (1 trials), "1.5% Arginine Dentifrice" (1 trials), "1X ACCS (Amnion-derived Cellular Cytokine Solution)" (1 trials) and "4.0% Arginine Dentifrice" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Forsyth Institute" are 17 trials for "All" genders.

Currently, there are NaN active trials in "The Forsyth Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in The Forsyth Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Forsyth Institute, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".